Skip to content

Bikanta

YC S14 · Inactive · Nano-diamonds for cancer detection

Competitors

Adjacent

Also from S14

All of S14

About Bikanta

Bikanta is introducing revolutionary nanodiamond-based technology to push the boundaries of current medical imaging and diagnostics, allowing researchers to answer questions and medics to detect diseases that they currently cannot. A nanodiamond is forever. They are brightly fluorescent, infinitely stable, non-toxic, functionalizable and can be used for background-free optical imaging. Early results have improved the signal by as much as 100-fold over conventional fluorescence imaging techniques. Bikanta’s vision is to redefine the boundaries of medical diagnostics by delivering cutting-edge imaging probes and background-free optical imaging.

YC batch
S14 · Summer 2014
Status, per YC
Inactive
Category
Other
Team size
2
Location
San Francisco, CA, USA; Berkeley, CA, USA
Checked
1h ago

YC tags: Nanomedicine

Bikanta in S14: 78 companies, 12% AI

Bikanta: questions

Which YC batch was Bikanta in?

Bikanta was in Y Combinator's Summer 2014 batch (S14).

Is Bikanta still active?

Y Combinator lists Bikanta as inactive.

Where is Bikanta based?

Bikanta lists San Francisco, CA, USA; Berkeley, CA, USA as its location on YC's directory.

Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.

New startups by email

Mondays: new YC data, AI and devtools companies and status changes, only when something changed.

Double opt-in. Unsubscribe any time.